Clinical trial
the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry
NCT04887571 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry
- Lead sponsor
- University of Cape Town
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2021
- Completion date
- May 31, 2022
- Enrollment
- 870 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, non st elevation myocardial infarction, st elevated myocardial infarction, unstable angina